William Jl Rieflin - 28 May 2021 Form 4 Insider Report for RAPT Therapeutics, Inc. (RAPT)

Role
Director
Signature
/s/ Rodney Young, Attorney-in-Fact for William Rieflin
Issuer symbol
RAPT
Transactions as of
28 May 2021
Transactions value $
$0
Form type
4
Filing time
24 Jun 2021, 20:17:41
Next filing
16 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAPT Stock Option (right to buy) Award $0 +7.5K $0.00 7.5K 28 May 2021 Common Stock 7.5K $19.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option shall vest on the earlier of (i) May 28, 2022, or (ii) one day prior to the date of the Issuer's next annual meeting of stockholders to be held in 2022, subject to the Reporting Person's continuous service through each applicable vesting date.